List of Excipients in API trastuzumab and hyaluronidase-oysk
✉ Email this page to a colleague
Detailed excipient profiles for trastuzumab and hyaluronidase-oysk
Excipient focus: HISTIDINE
trastuzumab and hyaluronidase-oysk drug variants containing HISTIDINE
Company | Ingredient | NDC |
---|---|---|
Genentech Inc | trastuzumab and hyaluronidase-oysk | 50242-077 |
>Company | >Ingredient | >NDC |
trastuzumab and hyaluronidase-oysk drug variants not containing HISTIDINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
trastuzumab and hyaluronidase-oysk drug variants containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Genentech Inc | trastuzumab and hyaluronidase-oysk | 50242-077 |
>Company | >Ingredient | >NDC |
trastuzumab and hyaluronidase-oysk drug variants not containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
trastuzumab and hyaluronidase-oysk drug variants containing METHIONINE
Company | Ingredient | NDC |
---|---|---|
Genentech Inc | trastuzumab and hyaluronidase-oysk | 50242-077 |
>Company | >Ingredient | >NDC |
trastuzumab and hyaluronidase-oysk drug variants not containing METHIONINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
trastuzumab and hyaluronidase-oysk drug variants containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
Genentech Inc | trastuzumab and hyaluronidase-oysk | 50242-077 |
>Company | >Ingredient | >NDC |
trastuzumab and hyaluronidase-oysk drug variants not containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TREHALOSE DIHYDRATE
trastuzumab and hyaluronidase-oysk drug variants containing TREHALOSE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Genentech Inc | trastuzumab and hyaluronidase-oysk | 50242-077 |
>Company | >Ingredient | >NDC |
trastuzumab and hyaluronidase-oysk drug variants not containing TREHALOSE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
trastuzumab and hyaluronidase-oysk drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Genentech Inc | trastuzumab and hyaluronidase-oysk | 50242-077 |
>Company | >Ingredient | >NDC |
trastuzumab and hyaluronidase-oysk drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.